Table 6.
Genotype | Clinical feature | Characteristic | Control | Case | OR (95% CI) | P-value |
---|---|---|---|---|---|---|
C/C | Sex | Female | 155 | 95 | Ref | |
Male | 150 | 120 | 1.31 (0.92–1.85) | 0.136287 | ||
C/T | Female | 89 | 54 | Ref | ||
Male | 72 | 58 | 1.33 (0.82–2.15) | 0.25070 | ||
T/T | Female | 17 | 51 | Ref | ||
Male | 17 | 41 | 0.8 (0.37–1.77) | 0.587 | ||
C/C | Age | < 45 | 142 | 50 | Ref | |
≥ 45 | 163 | 165 | 2.87 (1.95–4.24) | 9.77e−08 | ||
C/T | < 45 | 71 | 23 | Ref | ||
≥ 45 | 90 | 89 | 3.05 (1.75–5.31) | 7.88e−05 | ||
T/T | < 45 | 16 | 13 | Ref | ||
≥ 45 | 18 | 79 | 5.4 (2.21–13.19) | 0.000214 | ||
C/C | Addiction | No | 234 | 180 | Ref | |
Yes | 71 | 35 | 0.64 (0.41–1) | 0.05210 | ||
C/T | No | 131 | 95 | Ref | ||
Yes | 30 | 17 | 0.78 (0.41–1.5) | 0.4577 | ||
T/T | No | 22 | 78 | Ref | ||
Yes | 12 | 14 | 0.33 (0.13–0.81) | 0.016 |
Bold indicates a p-value less than 0.05 is statistically significant